MT-1 (Melanotan 1) Research Guide
What Is Melanotan 1 (MT-1)?
Melanotan 1 (MT-1), also known as Afamelanotide, is a synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH), a naturally occurring peptide involved in melanocortin signalling pathways.
Developed through peptide engineering, MT-1 was designed to replicate the activity of naturally occurring α-MSH while exhibiting greater stability. Its interaction with melanocortin receptors has made it an important subject of scientific investigation within peptide and receptor biology.
Today, Melanotan 1 is widely recognised as one of the principal compounds studied within melanocortin research.
Understanding How MT-1 Works
Melanotan 1 is classified as a melanocortin receptor agonist.
Researchers have investigated how MT-1 interacts primarily with melanocortin receptors, particularly those involved in pigmentation biology and peptide signalling pathways.
As a synthetic analogue of α-MSH, MT-1 has been extensively studied for its receptor-binding characteristics and its role within the broader melanocortin system.
Its relatively high receptor selectivity has made it a valuable compound within laboratory research.
Why Researchers Study MT-1
Melanotan 1 has been investigated across a variety of scientific disciplines, including:
- Melanocortin receptor biology
- Peptide-receptor interactions
- Pigmentation research
- Endocrine signalling
- Cellular communication pathways
- Synthetic peptide development
Its well-characterised structure and extensive scientific literature continue to make MT-1 an important research compound.
The Development of Melanotan 1
Melanotan 1 was developed as a synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH), a naturally occurring peptide produced within the body.
Researchers sought to produce a more stable peptide capable of interacting with melanocortin receptors while maintaining many of the characteristics of endogenous α-MSH.
Its development contributed significantly to advancing research into melanocortin receptor biology and synthetic peptide design.
What Makes MT-1 Different?
Unlike growth hormone peptides, neuropeptides and copper peptides, Melanotan 1 belongs to the melanocortin receptor agonist family.
It is also structurally distinct from Melanotan 2 (MT2). Although both compounds are synthetic analogues of α-MSH and belong to the same peptide family, they differ in structure, receptor binding characteristics and research applications.
This distinction has led researchers to investigate MT-1 and MT2 independently within melanocortin research.
MT-1 Compared to Other Research Peptides
Melanotan 1 (MT-1)
A synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH) primarily investigated within melanocortin receptor research.
Melanotan 2 (MT2)
A synthetic melanocortin receptor agonist with a different structure and receptor interaction profile.
Kisspeptin
A naturally occurring peptide involved in endocrine signalling and reproductive hormone research.
Oxytocin
A naturally occurring peptide hormone and neuropeptide studied within endocrine and neurological research.
Each compound possesses a unique structure, receptor profile and area of scientific investigation.
Product Specifications
Compound: Melanotan 1 (MT-1)
Alternative Name: Afamelanotide
Quantity: 10mg
Form: Lyophilised powder
Appearance: White to off-white powder
Storage: Store refrigerated upon receipt
Testing: Independently batch tested
Research Classification: Melanocortin Receptor Agonist
Independent Batch Testing
At Platinum Peptides, transparency and quality assurance remain central to our approach.
Every batch undergoes independent third-party analytical testing to verify identity and purity before being released.
Why Batch Testing Matters
Identity Verification
Confirms that the material matches the labelled compound.
Purity Analysis
Provides confidence that the sample meets established quality standards.
Consistency
Helps ensure batch-to-batch reliability and reproducibility.
Transparency
Allows researchers to review independent analytical data before making purchasing decisions.
Certificates of Analysis are available for each batch where applicable.
Storage Information
Lyophilised peptides should be stored in a cool, dry environment and protected from excessive heat, moisture and direct sunlight.
Researchers should always review appropriate storage conditions relevant to their specific protocols and applications.
Frequently Asked Questions
What is Melanotan 1?
Melanotan 1 (MT-1) is a synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH) and is classified as a melanocortin receptor agonist.
Is MT-1 the same as Afamelanotide?
Yes. Afamelanotide is the scientific name commonly used to refer to Melanotan 1.
Is Melanotan 1 naturally occurring?
No. Melanotan 1 is a synthetic peptide developed from the naturally occurring hormone alpha-melanocyte stimulating hormone (α-MSH).
What is the difference between MT-1 and MT2?
Although both compounds belong to the melanocortin peptide family, they differ in structure and receptor interaction characteristics, making them distinct research compounds.
What type of peptide is MT-1?
MT-1 is classified as a melanocortin receptor agonist.
Is Melanotan 1 batch tested?
Yes. Platinum Peptides uses independent third-party testing to verify batch quality and purity.
How should Melanotan 1 be stored?
Store in accordance with established peptide storage guidelines and maintain refrigeration where appropriate.
Related Research Compounds
Researchers interested in Melanotan 1 may also wish to explore:
Important Information
This product is supplied strictly for laboratory research purposes only.
It is not intended for human consumption, therapeutic use, diagnostic use or veterinary use.
Researchers are responsible for ensuring compliance with all applicable laws, regulations and research protocols relating to the handling and use of peptide compounds.
Platinum Peptides does not provide guidance regarding dosage, administration, usage protocols or expected effects. Researchers are responsible for conducting their own independent research.